Skip to main content

Table 2 Clinical outcomes in all patients

From: A prospective cohort study: platelet-rich plasma combined with carpal tunnel release treating carpal tunnel syndrome

 

1 month after surgery

3 months after surgery

6 months after surgery

Control Group

N = 39

PRP Group

N = 43

P

Control Group

N = 39

PRP Group

N = 43

P

Control Group

N = 39

PRP Group

N = 43

P

VAS

2.61 ± 1.19

2.39 ± 1.18

0.410

1.38 ± 1.05

1.46 ± 1.16

0.747

0.71 ± 1.10

0.81 ± 1.16

0.707

BCTQ-SSS

2.13 ± 0.58

1.91 ± 0.59

0.097

1.46 ± 0.64

1.39 ± 0.67

0.630

1.02 ± 0.86

0.93 ± 0.85

0.665

BCTQ-FSS

2.11 ± 0.63

1.94 ± 0.78

0.290

1.60 ± 0.69

1.64 ± 0.71

0.824

1.14 ± 0.87

1.20 ± 0.83

0.740

Grip strength (g/mm2)

18.01 ± 5.24

17.88 ± 5.05

0.852

20.68 ± 5.15

21.81 ± 5.12

0.909

22.87 ± 5.10

24.34 ± 5.59

0.222

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us